Study Details
Full Title
A randomized, placebo-controlled, double-blind Phase 3 study to evaluate the efficacy, safety and tolerability of votoplam in participants with Huntington’s Disease
Principal Investigator
Burton
Scott
Protocol Number
PRO00119676
NCT ID
NCT07326709
Phase
III
Enrollment Status
Open to Enrollment